[
  {
    "ts": "2026-02-19T01:16:29+00:00",
    "headline": "Zoetis Growth Outlook Shifts As Librela Concerns Weigh On Valuation",
    "summary": "Zoetis (NYSE:ZTS) is reporting delayed revenue growth expectations, with management now pointing to 2027 for a clearer inflection. The company is seeing slower uptake and demand challenges for Librela, its key canine arthritis pain therapy. Competitive products and reports of side-effect concerns are weighing on Librela’s traction in the market. Zoetis, a major animal health company focused on medicines, vaccines, and diagnostics for pets and livestock, is now dealing with a tougher setup...",
    "url": "https://finance.yahoo.com/news/zoetis-growth-outlook-shifts-librela-011629905.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "5e5ab39e-dffd-33cb-9991-198712e98164",
      "content": {
        "id": "5e5ab39e-dffd-33cb-9991-198712e98164",
        "contentType": "STORY",
        "title": "Zoetis Growth Outlook Shifts As Librela Concerns Weigh On Valuation",
        "description": "",
        "summary": "Zoetis (NYSE:ZTS) is reporting delayed revenue growth expectations, with management now pointing to 2027 for a clearer inflection. The company is seeing slower uptake and demand challenges for Librela, its key canine arthritis pain therapy. Competitive products and reports of side-effect concerns are weighing on Librela’s traction in the market. Zoetis, a major animal health company focused on medicines, vaccines, and diagnostics for pets and livestock, is now dealing with a tougher setup...",
        "pubDate": "2026-02-19T01:16:29Z",
        "displayTime": "2026-02-19T01:16:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/3a10ea4e2d99097fafd252f90cc495f0",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/f0C7t6iQjaUXO6Sb_gR7gg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/3a10ea4e2d99097fafd252f90cc495f0.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xjacLb9JseQC0Y25VVBzKQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/3a10ea4e2d99097fafd252f90cc495f0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-growth-outlook-shifts-librela-011629905.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-growth-outlook-shifts-librela-011629905.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T05:38:26+00:00",
    "headline": "The Top 5 Analyst Questions From Zoetis’s Q4 Earnings Call",
    "summary": "Zoetis’ fourth quarter results were met with a muted market reaction, as headwinds in the U.S. companion animal segment and margin pressures offset revenue growth. Management pointed to lingering economic challenges among U.S. pet owners, who became more price sensitive and reduced routine veterinary visits, while persistent competition in dermatology and parasiticides weighed on growth. CEO Kristin Peck noted, \"We continue to see some economic pressure on Gen Z and millennial pet owners, which",
    "url": "https://finance.yahoo.com/news/top-5-analyst-questions-zoetis-053826326.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "6166236d-1d48-37c2-99e3-263a81259ba3",
      "content": {
        "id": "6166236d-1d48-37c2-99e3-263a81259ba3",
        "contentType": "STORY",
        "title": "The Top 5 Analyst Questions From Zoetis’s Q4 Earnings Call",
        "description": "",
        "summary": "Zoetis’ fourth quarter results were met with a muted market reaction, as headwinds in the U.S. companion animal segment and margin pressures offset revenue growth. Management pointed to lingering economic challenges among U.S. pet owners, who became more price sensitive and reduced routine veterinary visits, while persistent competition in dermatology and parasiticides weighed on growth. CEO Kristin Peck noted, \"We continue to see some economic pressure on Gen Z and millennial pet owners, which",
        "pubDate": "2026-02-19T05:38:26Z",
        "displayTime": "2026-02-19T05:38:26Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/a3d0b8410287a32b42c8f0447c66312e",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ZTS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZIV_z_HWBQbAZAdlIXH86g--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/a3d0b8410287a32b42c8f0447c66312e.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2wbi11nRtAIpjCwNsAitnA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/a3d0b8410287a32b42c8f0447c66312e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-5-analyst-questions-zoetis-053826326.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-5-analyst-questions-zoetis-053826326.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]